---
title: "Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Shareholders to Reach Out"
description: "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against STAAR Surgical Company (STAA) following the company's disappointing financial results for Q4 2024, which included a GAAP ea"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/229606171.md"
published_at: "2025-02-25T15:06:09.000Z"
---

# Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Shareholders to Reach Out

> Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against STAAR Surgical Company (STAA) following the company's disappointing financial results for Q4 2024, which included a GAAP earnings per share of -$0.69 and revenue of $48.95 million, both missing estimates significantly. This led to a 24.68% drop in STAAR's stock price. Shareholders are encouraged to assist in the investigation by visiting the firm's website.

NEW YORK CITY, NY / ACCESS Newswire / February 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of STAAR Surgical Company ("STAAR" or "the Company") . Investors who purchased STAAR securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/STAA.

**Investigation Details**

On February 11, 2025, STAAR issued a press release reporting its financial results for the fourth quarter and full year 2024. Among other items, for the quarter, STAAR reported GAAP earnings per share of -$0.69, missing consensus estimates by $0.55, and revenue of $48.95 million, missing consensus estimates by $28.52 million. The Company attributed its results to "fluctuating demand in China". On this news, STAAR's stock price fell $5.40 per share, or 24.68%, to close at $16.48 per share on February 12, 2025.

**What's Next?**

If you are aware of any facts relating to this investigation or purchased STAAR securities, you can assist this investigation by visiting the firm's site: bgandg.com/STAA. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC:

**There is No Cost to You**

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

**Why Bronstein, Gewirtz & Grossman**

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising. Prior results do not guarantee similar outcomes.

**Contact**

**SOURCE:** Bronstein, Gewirtz & Grossman, LLC

View the original press release on ACCESS Newswire

### Related Stocks

- [STAA.US - STAAR Surgical](https://longbridge.com/en/quote/STAA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Broadwood Partners, L.P. 购入了 66,467 股达视光学（NASDAQ:STAA）的股票 | Broadwood Partners, L.P.以每股 22.00 美元的价格收购了 66,467 股 STAAR Surgical（纳斯达克代码：STAA），总计 1,462,274 美元。这次购买使他们的持股比例增加了 0.43%，使其 | [Link](https://longbridge.com/en/news/272074561.md) |
| Broadwood Partners 报告收购 STAAR Surgical 公司普通股 | Broadwood Partners, L.P. 已收购 STAAR Surgical Company (NASDAQ: STAA) 的普通股，相关信息在最近的 SEC Form 4 文件中披露。其他受益所有者包括 Broadwood Ca | [Link](https://longbridge.com/en/news/272486801.md) |
| 达视光学根据新的投资者协议重组董事会 | 达视光学与 Broadwood Partners 达成合作协议，导致其董事会进行重组。董事会成员将从六人扩展至七人，新任命包括 Broadwood 的高管和来自云启资本的 Christopher Wang。该协议导致董事会主席 Elizab | [Link](https://longbridge.com/en/news/272718818.md) |
| 达视光学公司宣布新的董事会主席和委员会调整 | 在 2026 年 1 月 15 日，达视光学宣布选举 Neal C. Bradsher 为新任董事会主席，并批准对其常设委员会进行变更。变更包括 Lilian Y. Zhou、Louis E. Silverman、Christopher M | [Link](https://longbridge.com/en/news/272843531.md) |
| 达视光学的首席执行官将作为与最大股东协议的一部分离职 | Staar Surgical 的首席执行官 Stephen Farrell 将在 1 月底辞职，这是与其最大股东 Broadwood Partners 达成和解的一部分。Farrell 和董事会主席 Elizabeth Yu 也已离开董事会 | [Link](https://longbridge.com/en/news/272711341.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.